Keywords: Acute systemic toxicity; Alternative approaches; Non-animal methods; Regulatory requirements; LD50; LC50; In vitro; In silico; AEGL; Acute Exposure Guideline Level; CBER; FDA Center for Biologics Evaluation and Research; CDER; FDA Center for Drug Evaluati
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Aβ1-42; 42-amino acid-long Aβ peptide; AD; Alzheimer's disease; ADAPT; Alzheimer's Disease Anti-Inflammatory Prevention Trial; ADAS-Cog; Alzheimer's Disease Assessment Scale-Cognitive Subscale; ADCS-ADL; Alzheimer's Disease Cooperative Study Activ
Keywords: Degradation products; Impurities; International chemical reference substances; Pharmacopoeial standards; Reference standards; Primary reference standards; Secondary reference standards; Working standards; AAS; atomic absorption spectroscopy; ANDA; abbrevi
Keywords: ABC; ATP-binding cassette; AP; absorption potential; API; active pharmaceutical ingredient; ATP; adenosine triphosphate; AZT; azidothymidine; BA/BE; bioavailability/bioequivalence; BCRP; breast cancer resistance protein; BCS; biopharmaceutical classificat
Keywords: AOAC; Association of Official Agricultural Chemists; AOCS; American Oil Chemists' Society; C30; triacontyl; CDER; Center for Drug Evaluation and Research; CPO; crude palm oil; GC; gas chromatography; HPLC; high, performance liquid chromatography; ICH; T
Keywords: Cell therapy; Minimally manipulated; Homologous use; Health Canada; Food and Drugs Act; Food and Drug Regulations; AHR Act; Assisted Human Reproduction Act of Canada; BGTD; Biologics and Genetic Therapies Directorate; CBER; Center for Biologics Evaluation
Keywords: Brain injuries; Life Expectancy; Mortality trends; Prognosis; Rehabilitation; Survival; CDDS; California Department of Developmental Services; CDER; Client Development Evaluation Report; CI; confidence interval; SCI; spinal cord injury; SMR; standardized
Keywords: Brain injuries; Mortality; Survival; Prognosis; Rehabilitation; Validation studies; CDDS; California Department of Developmental Services; CDER; Client Development Evaluation Report; CI; confidence interval; O/E; observed-to-expected; SSDI; Social Securit
Keywords: Breakthrough Therapy Designation; BTD; CDER; drug development; FDA; NME;
Keywords: Cardiac troponins; Biomarkers; Qualification; Analytical; Drug Development Tools; Safety assessment; Histopathology; BQRT; Biomarker Qualification Review Team; CDER; Center for Drug Evaluation and Research; CLSI; Clinical and Laboratory Standards Institut
Keywords: IEM; inborn errors of metabolism; NIH; National Institutes of Health; ODS; Office of Dietary Supplements; ORDR; Office of Rare Diseases Research; HRSA; Health Resources and Services Administration; PKU; phenylketonuria; PAH; phenylalanine hydroxylase; PHE
Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments
Keywords: ACR; American College of Radiology; AD; Alzheimer disease; ADNI; Alzheimer's Disease Neuroimaging Initiative; ALS; Amyotrophic Lateral Sclerosis; ASD; Autism Spectrum Disorder; BBB; Blood-Brain-Barrier; BEST; Biomarkers, Endpoints and other Tools; BLA; Bi
Review ArticleNeuroprosthetics and the science of patient input
Keywords: ACMC; Assessment of Capacity for Myoelectric Control; BCI; Brain-Computer Interface; CDER; Center for Drug Evaluation and Research; CDRH; Center for Devices and Radiological Health; DARPA; Defense Advanced Research Projects Agency; EMG; electromyogram; HD
Advancing pharmaceutical quality: An overview of science and research in the U.S. FDA's Office of Pharmaceutical Quality
Keywords: ADF; abuse deterrent formulation; API; active pharmaceutical ingredient; T-DM1; Ado-Trastuzumab Emtansine; ADC; antibody-drug conjugate; CDER; center for drug evaluation and research; CBRN/EID; chemical, biological, radiological/nuclear and emerging infec
Development of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation
Keywords: Ph.Eur.; European Pharmacopoeia; PEG 400; polyethylene glycol 400; TPGS 1000; d-alpha tocopheryl polyethylene glycol succinate 1000; PVA; polyvinyl alcohol; MC; methyl cellulose; HPC; hydroxypropyl cellulose; PDI; polydispersity index; HPLC; high-performa
A public-private consortium advances cardiac safety evaluation: Achievements of the HESI Cardiac Safety Technical Committee
Keywords: ADRs; adverse drug reactions; CDER; Center for Drug Evaluation and Research; cTn; cardiac troponin; CV; cardiovascular; EMA; European Medicines Agency; EWG; Expert Working Group; ECG; electrocardiogram; HESI; Health and Environmental Sciences Institute; h
Endoluminal reflux therapy: what do “FDA clearance” and “FDA approval” mean?
Keywords: CDER; Center for Drug Evaluation and Research; CDRH; Center for Devices and Radiologic Health; EG; esophagogastric; ERT; endoluminal reflux therapy; FDA; U.S. Food and Drug Administration; GERD-QOL; GERD quality of life; LES; lower esophageal sphincter; P
Human tumor cell lysates as a protein source for the detection of cancer antigen-specific humoral immunity
Keywords: CDER; Center for Drug Evaluation and Research; CLIA; Clinical Laboratory Improvement Act; CV; coefficient of variation; ELISA; enzyme-linked immunosorbent assay; FCS; fetal calf serum; HRP; horseradish peroxidase; NGS; normal goat serum; OD; optical densi